Glaxosmithkline Pharmaceuticals informs about analyst meet

15 Feb 2025 Evaluate
Pursuant to Regulation 30 read with Part A of Schedule Ill of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed that the recording is uploaded at Audio file – https://india-pharma.gsk.com/media/7833/analysts-meet-audio-recording-14th-feb-2025.mp3 Video file – https://india-pharma.gsk.com/media/7834/analysts-meet-video-recording-14th-feb-2025.mp4.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2592.50 32.45 (1.27%)
10-Dec-2025 14:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1784.35
Dr. Reddys Lab 1251.80
Cipla 1487.10
Zydus Lifesciences 926.65
Lupin 2055.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×